Lord, Abbett & Co. LLC Fulcrum Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.2 - $24.0 $792,334 - $4.53 Million	-188,651 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.96 - $23.65 $34,033 - $80,812	3,417 Added 1.84%	188,651 $4.46 Million
Q4 2021 Feb 11, 2022	SELL	$14.0 - $28.44 $25,326 - $51,447	-1,809 Reduced 0.97%	185,234 $3.28 Million
Q3 2021 Nov 09, 2021	BUY	$7.28 - $30.97 $1.36 Million - $5.79 Million	187,043 New	187,043 $5.28 Million

149

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $227M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.